AMENDMENT NO. 1 TO OFFER LETTEROffer Letter • November 7th, 2018 • Menlo Therapeutics Inc. • Pharmaceutical preparations
This Amendment No. 1 to Offer Letter (the “Amendment”) is entered into as of April 22, 2018, by and between Menlo Therapeutics Inc., a Delaware corporation (the “Company”) and Mary Spellman (“Executive”).
